Marine ω-3 PUFA Supplementation Enhances FFAR4 Activation and Reduces Inflammatory Markers in PBMC of Subjects with Obesity: A Randomized Controlled Trial (EPICO)
Nutrients · 2025
DOI: 10.3390/nu17233630 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2025. Verfasst von Samantha Desireé Reyes-Pérez und 10 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Nutrigenética y Nutrigenómica Traslacional, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340,…. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Leukocytes, Mononuclear, Obesity, Dietary Supplements. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Programa de Fortalecimiento de Institutos, Centros y Laboratorios de Investigación 2023; PIN 2024V; FODECIJAL; PRODEP UDG-PTC, Programa de Fortalecimiento de Institutos, Centros y Laboratorios de Investigación, PIN 2024-V.
Abstract (Originalsprache)
Background
It is widely accepted that low-grade chronic inflammation in obesity worsens the metabolic state and threatens patients’ lives in a long-term manner. In fact, diet therapy is the first-line treatment in which relevant nutrients such as the omega-3 polyunsaturated fatty acids (ω-3 PUFA) must be adequately consumed to counteract the established inflammation. In particular, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) have been identified as agonists of cellular receptors, including the free fatty acid receptor 4 (FFAR4), which regulates anti-inflammatory pathways associated with enhanced insulin sensitivity. However, the expression and activation of this receptor in peripheral blood mononuclear cells (PBMC) remains poorly investigated in humans.
Objective
This study aimed to evaluate the effect of a diet supplemented with marine ω-3 PUFA on FFAR4 receptor activation and inflammatory markers in peripheral blood mononuclear cells in subjects with obesity. Methodology: A double-blind, randomized clinical trial (NCT05068557) was conducted over two months (eight weeks) in 55 obese individuals (aged 25–59 years). Participants were randomly assigned to one of two groups: an active placebo group (1.6 g/day of alpha-linolenic acid) or a marine ω-3 group (1080 mg of EPA and 720 mg of DHA). Both groups followed a dietary regimen with progressive calorie restriction (−200 kcal/day during weeks 0–4 and −400 kcal/day during weeks 4–8) in addition to supplementation.
Results
Following the intervention, both groups showed significant improvements in body composition and biochemical parameters. Supplementation with EPA and DHA enhanced FFAR4 activation at the end of the intervention. Moreover, there was a reduction in the expression of JNK and IKKβ genes, as well as in serum levels of TNF-α, IL-6, and IL-18. In contrast, IL-10 levels increased significantly both within and between the groups.
Conclusions
Marine ω-3 PUFA supplementation, in the context of a dietary intervention, promotes FFAR4 activation, thereby contributing to the modulation of the inflammatory response in human PBMC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto de Nutrigenética y Nutrigenómica Traslacional, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.
- Doctorado en Ciencias en Biologia Molecular en Medicina, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.
- Doctorado en Ciencias de la Nutrición Traslacional, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44100, Jalisco, Mexico.
- Licenciatura de Nutrición, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.
- School of Medicine and Health Sciences, Tecnologico de Monterrey, General Ramon Corona Ave., 2514, Zapopan 45138, Jalisco, Mexico.
ORCID-Profile: Samantha Desireé Reyes-Pérez, Joel Torres-Vanegas, Juan J Rivera-Valdés, Nathaly Torres-Castillo, Evelyn Valencia-Sosa, Roberto Rodriguez-Echevarria, Erika Martinez-Lopez
Förderung
- Programa de Fortalecimiento de Institutos, Centros y Laboratorios de Investigación 2023; PIN 2024V; FODECIJAL; PRODEP UDG-PTC
- Programa de Fortalecimiento de Institutos, Centros y Laboratorios de Investigación
- PIN 2024-V
- COECYTJAL
Zitieren
APA
Reyes-Pérez, S. D., Cambron-Mora, D., Torres-Vanegas, J., Mojica-Zamudio, K. L., Olaez-Ramos, C. E., Lauriano-Rivera, R. G., Rivera-Valdés, J. J., Torres-Castillo, N., Valencia-Sosa, E., Rodriguez-Echevarria, R., & Martinez-Lopez, E. (2025). Marine ω-3 PUFA Supplementation Enhances FFAR4 Activation and Reduces Inflammatory Markers in PBMC of Subjects with Obesity: A Randomized Controlled Trial (EPICO). Nutrients. https://doi.org/10.3390/nu17233630
Vancouver
Reyes-Pérez SD, Cambron-Mora D, Torres-Vanegas J, Mojica-Zamudio KL, Olaez-Ramos CE, Lauriano-Rivera RG, et al. Marine ω-3 PUFA Supplementation Enhances FFAR4 Activation and Reduces Inflammatory Markers in PBMC of Subjects with Obesity: A Randomized Controlled Trial (EPICO). Nutrients. 2025. doi:10.3390/nu17233630
BibTeX
@article{ReyesPrez2025,
author = {Reyes-Pérez, Samantha Desireé and Cambron-Mora, Diego and Torres-Vanegas, Joel and Mojica-Zamudio, Karla Lizette and Olaez-Ramos, Carolina Elizabeth and Lauriano-Rivera, Ramon Gerardo and Rivera-Valdés, Juan J and Torres-Castillo, Nathaly and Valencia-Sosa, Evelyn and Rodriguez-Echevarria, Roberto and Martinez-Lopez, Erika},
title = {Marine ω-3 PUFA Supplementation Enhances FFAR4 Activation and Reduces Inflammatory Markers in PBMC of Subjects with Obesity: A Randomized Controlled Trial (EPICO)},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu17233630}
}
EUVIMED